Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,676,245
-
Share change
-
+2,202,120
-
Total reported value
-
$479,269,795
-
Price per share
-
$23.18
-
Number of holders
-
72
-
Value change
-
+$48,414,924
-
Number of buys
-
52
-
Number of sells
-
16
Institutional Holders of LOXO ONCOLOGY INC - COM (LOXO) as of Q2 2016
As of 30 Jun 2016,
LOXO ONCOLOGY INC - COM (LOXO) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,676,245 shares.
The largest 10 holders included
Aisling Capital LLC, FMR LLC, ORBIMED ADVISORS LLC, NEA Management Company, LLC, RS INVESTMENT MANAGEMENT CO LLC, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, and BlackRock Fund Advisors.
This page lists
72
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.